about
Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue CancersQuantitative Ultrasonic Nakagami Imaging of Neck Fibrosis After Head and Neck Radiation Therapy.Correlation of Acute and Late Brainstem Toxicities With Dose-Volume Data for Pediatric Patients With Posterior Fossa Malignancies.BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis.The role of radiotherapy for patients over age 60 with diffuse large B-cell lymphoma in the rituximab era.Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy.Radiation therapy and neutropenia.Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer.Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.A Phase 1 Study of Stereotactic Body Radiation Therapy Dose Escalation for Borderline Resectable Pancreatic Cancer After Modified FOLFIRINOX (NCT01446458).The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.T cells display mitochondria hyperpolarization in human type 1 diabetes.Prognostic relevance of human papillomavirus infection in anal squamous cell carcinoma: analysis of the national cancer data base.Health care disparities among octogenarians and nonagenarians with stage III lung cancer.Function Preservation After Conservative Resection and Radiotherapy for Soft-tissue Sarcoma of the Distal Extremity: Utility and Application of the Toronto Extremity Salvage Score (TESS).Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy.Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.Reproducibility in contouring the neurovascular bundle for prostate cancer radiation therapy.Chemotherapy with or Without Definitive Radiation Therapy in Inoperable Pancreatic Cancer.The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer.Adenosquamous Carcinoma of the Esophagus: An NCDB-Based Investigation on Comparative Features and Overall Survival in a Rare Tumor.Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic CarcinomasGonadal shielding technique to preserve fertility in male pediatric patients treated with total body irradiation for stem cell transplantationNeurovascular bundle-sparing radiotherapy for prostate cancer using MRI-CT registration: A dosimetric feasibility studySurvival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data BaseTargeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapyPrognostic value of radiographically defined extranodal extension in human papillomavirus-associated locally advanced oropharyngeal carcinoma
P50
Q31138958-E584289A-939B-4A4B-B0EF-32B760623BF6Q33585905-45E5E4FB-3DAA-49AA-AA56-FF337C998751Q35607081-8387C6C1-B7BD-4524-B4AA-07AA453D22E5Q36360392-B75A34BB-44B2-4787-8CD2-C5B51D02E097Q37090142-82F2E030-D99C-4596-8313-F80C56BF4162Q37104282-615BC9D7-3ED1-4505-AEF1-98B3111A30BFQ37578213-B8C8709B-5AAF-4DFB-BCC6-D4A48D76227DQ38570625-755D5748-E15D-454F-B2A6-2F61A9F11471Q38651907-18BC49E8-6580-4908-B9CF-8D663462D685Q38792423-EA920610-4170-4099-B4F4-6614A338C907Q38836088-A94CE3AA-54AB-4D3D-B3BD-66F817C74F3DQ38848059-30FBB6CA-ED83-476B-994A-D61AA6F72F8BQ39369140-8B8EB7CC-AA85-48E2-BCA2-9E4C5ED5FF5BQ40165007-378A6C79-DDDF-43EB-88AC-EAC4B71E362EQ41545654-4E942F91-33B8-45D3-83D8-C13F830C8031Q47128634-BA18D85E-B44D-4C83-8FEC-58CA887C15B6Q47189971-ABB2F347-557C-4818-8CCD-48955AB0621DQ48070549-C1CDDC0B-52FF-4AFF-BF9E-D0FECD46724DQ48146068-B09002AA-8B13-4CAF-BF72-5A21F444EDF2Q48387968-5D6785E5-2034-44DF-8BAC-06C54818EFB4Q49310050-27ACD62A-5242-4C77-A0FB-9E068918F5E5Q49914445-43149CD7-A6A7-4B91-8123-F40C365C402FQ50073661-4355D128-964C-4DD5-B96A-3A5E05B2BDD0Q51320797-F67145D2-E3B0-44D8-B510-E44A409829C3Q51799622-40532879-54B4-45E9-83A6-8CEEB86A5C94Q57159404-CF5B5D2C-A228-4DB4-8261-2EC804267170Q87417750-A0A6C368-81B5-49C6-89E3-179522FE3E46Q88561900-21C07DC8-FB42-4985-9052-26CFDEE72989Q90230336-83F2054F-768D-4B0D-BF24-0139070D3A10Q91017035-C19C9E63-F435-4020-B899-FF0904DA8051Q91694979-893CA0A5-9934-4AB6-880C-C0F669363B43
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Richard J. Cassidy
@ast
Richard J. Cassidy
@en
Richard J. Cassidy
@es
Richard J. Cassidy
@nl
Richard J. Cassidy
@sl
type
label
Richard J. Cassidy
@ast
Richard J. Cassidy
@en
Richard J. Cassidy
@es
Richard J. Cassidy
@nl
Richard J. Cassidy
@sl
altLabel
Rick Cassidy
@en
prefLabel
Richard J. Cassidy
@ast
Richard J. Cassidy
@en
Richard J. Cassidy
@es
Richard J. Cassidy
@nl
Richard J. Cassidy
@sl
P106
P1153
56567705500
P21
P31
P3835
richard-cassidy3
P496
0000-0003-0019-0679